1 results match your criteria: "EA 3035 and Department of Clinical Biology[Affiliation]"
Clin Cancer Res
April 2005
EA 3035 and Department of Clinical Biology, Institut Claudius-Regaud, Toulouse, France.
Purpose: To evaluate plasma cystatin level as a covariate to predict topotecan pharmacokinetics. Cystatin C, a member of the cystatin superfamily of cysteine proteinase inhibitors, has been recently proposed as an alternative endogenous marker of glomerular filtration. Renal function is known as a key factor of topotecan clearance.
View Article and Find Full Text PDF